Bullish
FTSE 100 rises 1.7% to 10,652.9, highest since April 17, 2026.
In the past 24 hours, the FTSE 100 has experienced a significant rally, closing at 10,652.9 points on July 2, 2026, its highest level since April 17, 2026. This surge was primarily driven by strong performances in the pharmaceutical and defense sectors, as well as positive corporate developments.
Key points
- Pharmaceutical stocks led the rally, with AstraZeneca gaining 4.9% after announcing a deal worth up to $1.77 billion with China's CSPC Pharmaceutical Group to develop kidney treatments.
- Defense stocks also saw significant gains, with BAE Systems and Babcock International rising 6.1% and 5.5%, respectively, bolstering the index's performance.
- The broader market sentiment was supported by easing concerns over potential interest rate hikes by the Federal Reserve, following a softer-than-expected U.S. jobs report.
- Investors are awaiting upcoming U.S. non-farm payrolls data, which could provide further insights into the labor market and influence future market movements.
Sources
AI-generated from public news sources. Not financial advice.
